prof. dr. G. Dijkstra

No picture available
E-mail:
gerard.dijkstra umcg.nl

Research

  1. 2021
  2. 2020
  3. Parelsnoer Institute and the Dutch Initiative on Crohn and Colitis, Voskuil, M. D., Spekhorst, L. M., van der Sloot, K. W. J., Jansen, B. H., Dijkstra, G., van der Woude, C. J., Hoentjen, F., Pierik, M. J., van der Meulen, A. E., de Boer, N. K. H., Löwenberg, M., Oldenbrug, B., Festen, E. A. M., & Weersma, R. K. (2020). Genetic risk scores identify genetic aetiology of inflammatory bowel disease phenotypes. Journal of Crohn's and Colitis. https://doi.org/10.1093/ecco-jcc/jjaa223
  4. Pachera, E., Assassi, S., Salazar, G. A., Stellato, M., Renoux, F., Wunderlin, A., Blyszczuk, P., Lafyatis, R., Kurreeman, F., de Vries-Bouwstra, J., Messemaker, T., Feghali-Bostwick, C. A., Rogler, G., van Haaften, W. T., Dijkstra, G., Oakley, F., Calcagni, M., Schniering, J., Maurer, B., ... Distler, O. (2020). Long noncoding RNA H19X is a key mediator of TGF-beta-driven fibrosis. CLIN Journal, 130(9), 4888-4905. https://doi.org/10.1172/JCI135439
  5. Canovai, E., Oltean, M., Herlenius, G., Akyurek, L. M., Trentadue, G., Dijkstra, G., Haveman, J. W., Pascher, A., De Hertogh, G., Monbaliu, D., Pirenne, J., & Ceulemans, L. J. (2020). IGL-1 as a preservation solution in intestinal transplantation: a multicenter experience. Transplant International, 33(8), 963-965. https://doi.org/10.1111/tri.13625
  6. de Jong, M. J., Boonen, A., van der Meulen-de Jong, A. E., Romberg-Camps, M. J., van Bodegraven, A. A., Mahmmod, N., Markus, T., Dijkstra, G., Winkens, B., van Tubergen, A., Masclee, A., Jonkers, D. M., & Pierik, M. J. (2020). Cost-effectiveness of Telemedicine-directed Specialized vs Standard Care for Patients With Inflammatory Bowel Diseases in a Randomized Trial. Clinical Gastroenterology and Hepatology, 18(8), 1744-1752. https://doi.org/10.1016/j.cgh.2020.04.038
  7. Dutch Initiative on Crohn and Colitis, Biemans, V. B. C., van der Woude, C. J., Dijkstra, G., van der Meulen-de Jong, A. E., Lowenberg, M., de Boer, N. K., Oldenburg, B., Srivastava, N., Jansen, J. M., Bodelier, A. G. L., West, R. L., de Vries, A. C., Haans, J. J. L., de Jong, D., Hoentjen, F., & Pierik, M. J. (2020). Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn's disease patients with prior failure to anti-TNF treatment. Alimentary Pharmacology & Therapeutics, 52(1), 123-134. https://doi.org/10.1111/apt.15745
  8. ICC, Kreijne, J. E., de Vries, A. C., de Veer, R. C., Bouma, G., Dijkstra, G., Voskuil, M. D., West, R., van Moorsel, S. A. W., de Jong, D. J., de Boer, N. K., & van der Woude, C. J. (2020). Limited added value of laboratory monitoring in thiopurine maintenance monotherapy in inflammatory bowel disease patients. Alimentary Pharmacology & Therapeutics, 51(12), 1353-1364. https://doi.org/10.1111/apt.15734
  9. Dutch Initiative on Crohn and Colitis, Biemans, V. B. C., Sleutjes, J. A. M., de Vries, A. C., Bodelier, A. G. L., Dijkstra, G., Oldenburg, B., Löwenberg, M., van Bodegraven, A. A., van der Meulen-de Jong, A. E., de Boer, N. K. H., Srivastava, N., West, R. L., Römkens, T. E. H., Horjus Talabur Horje, C. S., Jansen, J. M., van der Woude, C. J., Hoekstra, J., Weersma, R. K., ... Pierik, M. J. (2020). Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry. Alimentary Pharmacology & Therapeutics, 51(9), 880-888. https://doi.org/10.1111/apt.15689
  10. Dutch Initiative on Crohn and Colitis, Biemans, V. B. C., van der Woude, C. J., Dijkstra, G., van der Meulen-de Jong, A. E., Oldenburg, B., de Boer, N. K., Loewenberg, M., Srivastava, N., Bodelier, A. G. L., West, R. L., Jansen, J. M., de Vries, A. C., Haans, J. J. L., de Jong, D. J., Pierik, M. J., & Hoentjen, F. (2020). Vedolizumab for Inflammatory Bowel Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study: ICC Registry - Vedolizumab. Clinical Pharmacology & Therapeutics, 107(5), 1189-1199. https://doi.org/10.1002/cpt.1712
  11. Barnhoorn, M. C., Wasser, M. N. J. M., Roelofs, H., Maljaars, P. W. J., Molendijk, I., Bonsing, B. A., Oosten, L. E. M., Dijkstra, G., van der Woude, C. J., Roelen, D. L., Zwaginga, J-J., Verspaget, H. W., Fibbe, W. E., Hommes, D. W., Peeters, K. C. M. J., & van der Meulen-de Jong, A. E. (2020). Long-term Evaluation of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy for Crohn's Disease Perianal Fistulas. Journal of Crohn's and Colitis, 14(1), 64-70. https://doi.org/10.1093/ecco-jcc/jjz116
  12. Dutch Initiative on Crohn and Colitis, Biemans, V. B. C., van der Meulen-de Jong, A. E., van der Woude, C. J., Lowenberg, M., Dijkstra, G., Oldenburg, B., de Boer, N. K. H., van der Marel, S., Bodelier, A. G. L., Jansen, J. M., Haans, J. J. L., Theeuwen, R., de Jong, D., Pierik, M. J., & Hoentjen, F. (2020). Ustekinumab for Crohn's Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study. Journal of Crohn's and Colitis, 14(1), 33-45. https://doi.org/10.1093/ecco-jcc/jjz119
  13. Dutch Initiative on Crohn and Colitis, Asscher, V. E. R., Biemans, V. B. C., Pierik, M. J., Dijkstra, G., Löwenberg, M., van der Marel, S., de Boer, N. K. H., Bodelier, A. G. L., Jansen, J. M., West, R. L., Haans, J. J. L., van Dop, W. A., Weersma, R. K., Hoentjen, F., & Maljaars, P. W. J. (2020). Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab- and ustekinumab-treated patients with inflammatory bowel disease-a prospective multicentre cohort study. Alimentary Pharmacology & Therapeutics, 52(8), 1366-1376. https://doi.org/10.1111/apt.16073
  14. Dutch-Belgian The Effect of Vitamin D3 to Prevent Postoperative Relapse of Crohn’s Disease: A Placebo-controlled Randomized Trial Study Group (2020). High-Dose Vitamin D Does Not Prevent Postoperative Recurrence of Crohn's Disease in a Randomized Placebo-Controlled Trial. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2020.05.037
  15. 2019
  16. Raselli, T., Wyss, A., Alvarado, M. N. G., Weder, B., Mamie, C., Spalinger, M. R., van Haaften, W. T., Dijkstra, G., Sailer, A. W., Silva, P. H. I., Wagner, C. A., Tosevski, V., Leibl, S., Scharl, M., Rogler, G., Hausmann, M., & Misselwitz, B. (2019). The Oxysterol Synthesising Enzyme CH25H Contributes to the Development of Intestinal Fibrosis. Journal of Crohn's and Colitis, 13(9), 1186-1200. https://doi.org/10.1093/ecco-jcc/jjz039, https://doi.org/10.1093/ecco-jcc/jjz039
Previous 1 2 3 4 5 Next

ID: 220507